Treatment response and 5-year distant metastasis-free survival outcome in breast cancer patients after the use of MammaPrint and BluePrint to guide preoperative systemic treatment decisions
2022 · European Journal of Cancer · 13 citations
https://doi.org/10.1016/j.ejca.2022.03.003